Financials and pharma stocks led the advance amid positive flows from foreign portfolio investors
The Nifty Pharma index finished at 12,750, up 3.1 per cent - most since May 20 and third biggest single-day gain of the year
'Defying global trends, Nifty 50 has outperformed most peers year-to-date and is trading at 19.2 times, 21% above its long-term average, taking the earnings yield-bond yield gap below 2%'
Further evidence of economic resilience and animal spirits, according to Wood, is continuing strong goods and services tax (GST) revenues and buoyant retail sales
Between 2011-12 and FY22, the market value of FPI holdings had increased at an annualised rate of 16.5 per cent in local currency terms and a modest 11.5 per cent in US dollar terms
Fed remarks, China growth concerns hit sentiment
The relentless rally is underpinned by falling crude oil prices, revival in foreign investor flows and improving economic outlook
Business Standard brings you the top headlines at this hour
Annual ETF investments of nearly Rs 36,000 cr on average since 2019-20
Stocks to Watch today: Cigarettes-to-hotels major ITC on Monday reported a 33.98 per cent year-on-year (YoY) jump in its consolidated net profit, which came in at Rs 4,389.76 crore
Stocks to Watch today: ITC, UPL, Zomato, Arvind, Bajaj Consumer Care, among others will release their Q1 earnings today.
However, analysts do caution against intermittent phases of withdrawals by FIIs given macro-economic developments across major world economies
Despite a record rise in trading by retail investors over the past eight years, Indian households remain "dramatically" underweight in the asset class, says Ridham Desai
More than the Fed's hike, it is the commentary that would impact market sentiment
Stick to proven fund houses with at least a 5-year track record and see how they performed over market phases
Adani Enterprises (AEL) is pegged to replace Kolkata-based Shree Cement in the Nifty 50 index, a gauge for the performance of India's capital market
Coverage may improve as more funds start chasing the stock, say market experts
Employee costs rose over 12% in FY22, the fastest in 8 years
The latest gain comes on the back of easing commodity prices and supply chain issues
It is difficult to purchase such stocks during bull runs when their valuations turn exorbitant